Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Paxil Subpoena Documents Protected By Attorney-Client Privilege – Court

Executive Summary

The Federal Trade Commission's investigations into late-listed pharmaceutical patents could face a hurdle in the attorney-client privilege, an appellate court decision suggests

You may also be interested in...



Paxil Late-Listed Patents Are Questionable For Orange Book Listing – FTC

Generic versions of Paxil are being held up by patents whose listing in the "Orange Book" is questionable, the Federal Trade Commission's generic drug report states

Paxil Late-Listed Patents Are Questionable For Orange Book Listing – FTC

Generic versions of Paxil are being held up by patents whose listing in the "Orange Book" is questionable, the Federal Trade Commission's generic drug report states

GSK Supports Waxman/Hatch Trade: Drop Bolar, Remove 30-Month Stays

GlaxoSmithKline supports a legislative deal to change the 30-month stays on generic approvals during patent litigation in return for having generic firms give up their right to do development work on drugs prior to patent expiration

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel